Acromegaly-Associated Hypertension, Endocrine Hypertension Syndromes, Hypertension - Full Vignette w скачать в хорошем качестве

Acromegaly-Associated Hypertension, Endocrine Hypertension Syndromes, Hypertension - Full Vignette w

A 56-year-old woman with a history of hypertension and recent sepsis presents with progressive enlargement of her hands, feet, and facial features, worsening headaches, and visual disturbances. Despite intervention for infection and withholding beta-blockers due to bradycardia, her blood pressure remains uncontrolled. What clinical considerations should guide your approach to managing persistent hypertension in a patient with these systemic findings and pituitary imaging abnormalities? VIDEO INFO Category: Acromegaly-Associated Hypertension, Endocrine Hypertension Syndromes, Hypertension Difficulty: Moderate - Intermediate level - Requires solid foundational knowledge Question Type: Management - Clinical management decisions Case Type: Critical Condition Explore more ways to learn on this and other topics by going to https://endlessmedical.academy/auth?h... QUESTION A 56-year-old woman is admitted to the intensive-care unit with sepsis from a right-sided obstructive Escherichia coli pyelonephritis. Over the past 8 months she has noticed progressive enlargement of her hands, feet, and facial features, worsening headaches, and intermittent blurry vision. She has had long-standing hypertension treated with metoprolol succinate 200 mg nightly. Past medical history includes polymyalgia rheumatica managed with prednisone 5 mg daily.... OPTIONS A. Schedule transsphenoidal resection of the growth-hormone-secreting pituitary macroadenoma within the next 4-6 weeks once the acute infection has resolved B. Begin long-acting octreotide therapy as first-line treatment for the pituitary macroadenoma after she is stabilized C. Switch metoprolol to carvedilol and titrate to the maximum tolerated dose after discharge D. Add spironolactone 25 mg daily to counteract growth-hormone-mediated sodium retention CORRECT ANSWER A. Schedule transsphenoidal resection of the growth-hormone-secreting pituitary macroadenoma within the next 4-6 weeks once the acute infection has resolved EXPLANATION Transsphenoidal resection of the growth-hormone-secreting pituitary macroadenoma is the intervention most likely to abolish the hormonal driver of this patient s hypertension. Per the 2014 Endocrine Society acromegaly guideline, surgery is first-line for tumors that are surgically accessible or producing visual-field compromise because it offers the highest probability of rapid biochemical remission, improvement in blood pressure, and protection of the optic chiasm. Prospective series show that successful resection normalizes or substantially lowers blood pressure in up to one-half of patients and reverses concentric left-ventricular hypertrophy within months; blood-pressure benefits often parallel the fall in growth hormone and insulin-like growth factor-1. Elective scheduling 4-6 weeks after resolution of sepsis balances infectious-risk reduction against the need to prevent permanent visual loss and ongoing vascular remodeling. Beginning long-acting octreotide after stabilization achieves biochemical control in only 50-70 percent of cases and rarely produces timely visual improvement, so it is inferior to surgery. Switching metoprolol to carvedilol targets sympathetic tone yet ignores the hormonal stimulus and risks worsening the existing bradycardia. Adding spironolactone counters volume expansion but does nothing for the increased systemic vascular resistance or endothelial dysfunction driven by insulin-like growth factor-1, and therefore cannot serve as definitive management. --------------------------------------------------- Our cases and questions come from the https://EndlessMedical.Academy quiz engine - multi-model platform. Each question and explanation is forged by consensus between multiple top AI models (i.e. Open AI GPT, Claude, Grok, etc.), with automated web searches for the latest research and verified references. Calculations (e.g. eGFR, dosages) are checked via code execution to eliminate errors, and all references are reviewed by several AIs to minimize hallucinations. Important note: This material is entirely AI-generated and has not been verified by human experts; despite stringent consensus checks, perfect accuracy cannot be guaranteed. Exercise caution - always corroborate the content with trusted references or qualified professionals, and never apply information from this content to patient care or clinical decisions without independent verification. Clinicians already rely on AI and online tools - myself included - so treat this content as an additional focused aid, not a replacement for proper medical education. Visit https://endlessmedical.academy for more AI-supported resources and cases. This material can not be treated as medical advice. May contain errors. ---------------------------------------------------